Cargando…
Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone
Data have demonstrated that COCs, besides offering a satisfactory and safe contraception, offer a variety of non-contraceptive health benefits and therapeutic positive aspects. Many prescribes and users, however, do not realize these positive aspects especially the non-contraceptive health benefits....
Autores principales: | Regidor, Pedro-Antonio, Schindler, Adolf E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669973/ https://www.ncbi.nlm.nih.gov/pubmed/29137347 http://dx.doi.org/10.18632/oncotarget.19833 |
Ejemplares similares
-
Dienogest in long-term treatment of endometriosis
por: Schindler, Adolf E
Publicado: (2011) -
The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018) -
Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
por: Palacios, Santiago, et al.
Publicado: (2020) -
A single-arm study to evaluate the transfer of drospirenone to breast
milk after reaching steady state, following oral administration of 4 mg
drospirenone in healthy lactating female volunteers
por: Melka, Dace, et al.
Publicado: (2020) -
Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)